Correction to: Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer’s Disease in Wistar Rats (Neurochemical Research, (2015), 40, 4, (767-776), 10.1007/s11064-015-1525-1);Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer’s Disease in Wistar Rats

Neurochemical Research

Volumn 40, Issue 4, 2015, Pages 767-776

  Thenmozhi, Arokiasamy Justin ^a   Raja, Tharsius Raja William ^a   Janakiraman, Udaiyappan ^a   Manivasagam, Thamilarasan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

AlCl3; Alzheimer s disease; A synthesis; Hesperidin; Memory loss

Indexed keywords

ALUMINUM CHLORIDE; ALUMINUM DERIVATIVE; CHLORIDE; HESPERIDIN; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED; MALE; RAT; WISTAR RAT;

ALUMINUM COMPOUNDS; ALZHEIMER DISEASE; ANIMALS; BEHAVIOR, ANIMAL; CHLORIDES; HESPERIDIN; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 84937572354     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-022-03616-x     Document Type: Erratum

References (57)

1. Cam JA, Bu GJ (2006) Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family. Mol Neurodegener 8:1–13
2. Ribes D, Colomina MT, Vicens P, Domingo JL (2008) Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer’s disease. Exp Neurol 214:293–300
3. Akila R, Stollery BT, Riihimaki V (1999) Decrements in cognitive performance in metal inert gas welders exposed to aluminium. Occup Environ Med 56:632–639
4. Drago D, Folin M, Baiguera S, Tognon G, Ricchelli F, Zatta P (2007) Comparative effects of Abeta(1–42)-Al complex from rat and human amyloid on rat endothelial cell cultures. J Alzheimers Dis 11:33–44
5. Zaky A, Mohammad B, Moftah M, Kandeel KM, Bassiouny AR (2013) Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation. BMC Neurosci 14:26
6. Gulya K, Rakonczay Z, Kasa P (1990) Cholinotoxic effects of aluminium in rat brain. J Neurochem 54:1020–1026
7. Rakonczay Z, Horváth Z, Juhász A, Kálmán J (2005) Peripheral cholinergic disturbances in Alzheimer’s disease. Chem Biol Interact 157–158:233–238
8. Standridge JB (2004) Pharmacotherapeutic approaches to the prevention of Alzheimer’s disease. Am J Geriatr Pharmacother 2:119–132
9. Espín JC, García-Conesa MT, Tomás-Barberán FA (2007) Nutraceuticals: facts and fiction. Phytochemistry 68:2986–3008
10. Spencer JP (2007) The interactions of flavonoids within neuronal signalling pathways. Genes Nutr 2:257–273
11. Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, Bickford PC (1999) Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19:8114–8121
12. Gaur V, Aggarwal A, Kumar A (2011) Possible nitric oxide mechanism in the protective effect of hesperidin against ischemic reperfusion cerebral injury in rats. Indian J Exp Biol 49:609–618
13. Salem HRA, El-Raouf AA, Saleh EM, Shalaby KAF (2012) Influence of hesperidin combined with Sinemet on genetical and biochemical abnormalities in rats suffering from Parkinson’s disease. Life Sci J 9:930–945
14. Dimpfel W (2006) Different anticonvulsive effects of hesperidin and its aglycone hesperetin on electrical activity in the rat hippocampus in-vitro. J Pharm Pharmacol 58:375–379
15. Kumar P, Kumar A (2010) Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington’s like symptoms in rats: possible role of nitric oxide. Behav Brain Res 206:38–46
16. Raza SS, Khan MM, Ahmad A, Ashafaq M, Khuwaja G, Tabassum R, Javed H, Siddiqui MS, Safhi MM, Islam F (2011) Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke. Brain Res 1420:93–105
17. Ikemura M, Sasaki Y, Giddings JC, Yamamoto J (2012) Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats. Phytother Res 26:1272–1277
18. Viswanatha GL, Shylaja H, Sandeep Rao KS, Santhosh Kumar VR, Jagadeesh M (2012) Hesperidin ameliorates immobilization-stress-induced behavioral and biochemical alterations and mitochondrial dysfunction in mice by modulating nitrergic pathway. ISRN Pharmacol 479–570
19. Abdel-Aal RA, Assi AA, Kostandy BB (2011) Rivastigmine reverses aluminum-induced behavioral changes in rats. Eur J Pharmacol 659:169–176
20. Fernagut PO, Diguet E, Stefanova N, Biran M, Wenning GK, Canioni P, Bioulac B, Tison F (2002) Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience 114:1005–1017
21. Sethi P, Jyoti A, Singh R, Hussain E, Sharma D (2008) Aluminium-induced electrophysiological, biochemical and cognitive modifications in the hippocampus of aging rats. Neurotoxicology 29:1069–1079
22. Morris R (1984) Developments of a water maze procedure for studing spatial learning in the rat. J Neurosci Methods 11:47–60
23. RajaSankar S, Manivasagam T, Surendran S (2009) Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson’s disease. Neurosci Lett 454:11–15
24. Erazi H, Sansar W, Ahboucha S, Gamrani H (2010) Aluminum affects glial system and behavior of rats. C R Biol 333:23–27
25. Hartmann M, Heumann R, Lessmann V (2001) Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J 20:5887–5897
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
27. Annida B, Menon VP (2007) Protective effect of hesperidin on nicotine induced toxicity in rats. Indian J Exp Biol 45:194–202
28. Sakamoto T, Ogasawara Y, Ishii K, Takahashi H, Tanabe S (2004) Accumulation of aluminum in ferritin isolated from rat brain. Neurosci Lett 366:264–267
29. Abubakar MG, Taylor A, Ferns GAA (2004) Regional accumulation of aluminium in the rat brain is affected by dietary vitamin E. J Trace Elem Med Biol 18:53–59
30. Roskams AJ, Connor JR (1990) Aluminum access to the brain: a role for transferrin and its receptors. Proc Natl Acad Sci USA 87:9024–9027
31. Kaur A, Gill KD (2006) Possible peripheral markers for chronic aluminium toxicity in Wistar rats. Toxicol Ind Health 22:39–46
32. Crapper DR, Krishnan SS, Dalton AJ (1973) Brain aluminum distribution in Alzheimer’s disease and experimental neurofibrillary degeneration. Science 180:511–513
33. Pavun LA, Dimitricmarkovic JM, Durdevic PT, Jelikic-Stankov MD, Dikanovic DB, Ciric AR, Malesev DL (2012) Development and validation of a fluorometric method for the determination of hesperidin in human plasma and pharmaceutical forms. J Serb Chem Soc 77:1625–1640
34. Shagirtha K, Pari L (2011) Hesperetin, a citrus flavonone, protects potentially cadmium induced oxidative testicular dysfunction in rats. Ecotoxicol Environ Saf 74:2105–2111
35. Kuntic V, Filipovic I, Vujic Z (2011) Effects of rutin and hesperidin and their Al(III) and Cu(II) complexes on in vitro plasma coagulation assays. Molecules 16:1378–1388
36. Amberla K, Nordberg A, Viitanen M, Winblad B (2009) Long-term treatment with tacrine (THA) in Alzheimers disease evaluation of neuropsychological data. Acta Neurol Scand Suppl 149:55–57
37. Zheng H, Youdim MB, Fridkin M (2009) Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer’s therapy. J Med Chem 52:4095–4098
38. Zatta P, Zambenedetti P, Bruna V, Filippi B (1994) Activation of acetylcholinesterase by aluminium(III): the relevance of the metal species. NeuroReport 5:1777–1780
39. Kakkar V, Kaur IP (2011) Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol 49:2906–2913
40. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer’s disease. Lancet 368:387–403
41. Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J (2004) Cholinesterase inhibitors used in the treatment of Alzheimer’s disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 21:453–478
42. Javed H, Vaibhav K, Ahmed ME, Khan A, Tabassum R, Islam F, Safhi MM, Islam F (2014) Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice. J Neurol Sci (in press)
43. Young-Pearse TL, Chen AC, Chang R, Marquez C, Selkoe DJ (2008) Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1. Neural Dev 3:15
44. Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca G, Danni O, Zhu XW, Smith MA, Perry G, Jo DG, Mattson MP, Tabaton M (2008) Oxidative stress activates a positive feedback between the γ- and β-secretase cleavages of the β-amyloid precursor protein. J Neurochem 104:683–695
45. Lin R, Chen X, Li W (2008) Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin. Neurosci Lett 440:344–347
46. Luo HB, Yang JS, Shi XQ (2009) Tetrahydroxy stilbene glucoside reduces the cognitive impairment and overexpression of amyloid precursor protein induced by aluminum exposure. Neurosci Bull. 25:391–396
47. Lukiw WJ, Percy ME, Kruck TP (2005) Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J Inorg Biochem 99:1895–1898
48. Alexandrov PN, Zhao Y, Pogue AI, Tarr MA, Kruck TP, Percy ME, Cui JG, Lukiw WJ (2005) Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells. J Alzheimer’s Dis 8:117–127
49. Ghorbani A, Nazari M, Jeddi-Tehrani M, Zand H (2012) The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ-dependent mechanism. Eur J Nutr 51:39–46
50. Nazari M, Ghorbani A, Hekmat-Doost A, Jeddi-Tehrani M, Zand H (2011) Inactivation of nuclear factor-κB by citrus flavanone hesperidin contributes to apoptosis and chemo-sensitizing effect in Ramos cells. Eur J Pharmacol 650:526–533
51. Kim JY, Jung KJ, Choi JS, Chung HY (2006) Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell 5:401–411
52. Cochran M, Elliott DC, Brennan P, Chawtur V (1990) Inhibition of protein kinase C activation by low concentrations of aluminium. Clin Chim Acta 194:167–172
53. Caporaso GL, Gandy SE, Buxbaum JD, Ramabhadran TV, Greengard P (1992) Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89:3055–3059
54. Kawahara M, Kato M, Kuroda Y (2001) Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res Bull 55:211–217
55. Li C, Zug C, Qu H, Schluesener H, Zhang Z (2016) Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice. Behav Brain Res 281:32–42
56. Bastianetto S, Brouillette J, Quirion R (2007) Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin. Neurochem Res 32:1720–1725
57. Levites Y, Amit T, Youdim MB, Mandel S (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (−)-epigallocatechin-3-gallate neuronprotective action. J Biol Chem 277:30574–30580